5 ETFs to Watch as Restrictions on Marijuana Set to Ease

Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.

ETF Trends • Dec 12, 2025

Disruptive Theme of the Week: Top YTD Themes in the Rearview Mirror

It may not be the end of the quarter yet, but we have made it through summer, and that seems like a good checkpoint to evaluate the top ETF investment themes YTD. Let's take a moment to look in this year's thematic ETF rearview mirror.

ETF Trends • Sep 10, 2025

US cannabis stocks rally as Trump backs rescheduling

Investors are closely watching the US cannabis space after President Donald Trump signaled plans to reschedule marijuana, a move that is expected to unlock near-term financial relief and longer-term growth for the industry. Trump recently stated that his administration will “be moving forward soon with rescheduling marijuana,” referring to its reclassification as a lower-risk Schedule III drug.

Proactive Investors • Aug 26, 2025

Top-Performing ETFs of Last Week

ETFs tied to cannabis, Ethereum and Chinese tech stocks topped last week's winners list. Top performers were KSTR, YOLO, ARKZ, CHIQ and CNXT.

Zacks Investment Research • Aug 26, 2025

Disruptive Theme of the Week: Cannabis Staging a Comeback

Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous drug.

ETF Trends • Aug 19, 2025

Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization

Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.

New York Post • Nov 7, 2024

AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market

With cannabis approaching a pivotal juncture, AdvisorShares provides key investment exposure to multi-state operators through its industry-leading ETF suite BETHESDA, Md. , Oct. 21, 2024 /PRNewswire/ -- The U.S. cannabis market is approaching historic regulatory reforms, which AdvisorShares is monitoring closely as an investment leader in this specialized sector.

PRNewsWire • Oct 21, 2024

Cannabis stocks rally as Trump backs rescheduling, Florida legalization

Cannabis shares gained traction during Monday's session after Donald Trump endorsed the federal rescheduling of marijuana to allow research into its medical benefits. In a post on his social media platform Truth Social, the Republic presidential candidate said his administration would pass “common sense laws,” specifically the SAFER Banking Act and rescheduling cannabis to the lower-risk Schedule 3 of the Controlled Substances Act.

Proactive Investors • Sep 9, 2024

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election

Cannabis stocks moved lower on Tuesday as hopes that marijuana could be rescheduled as a lower-risk drug in the US before the upcoming election in November were dashed. Earlier this year, the Department of Justice (DOJ) in line with a recommendation from the Department of Health and Human Services proposed that because marijuana has accepted medical uses and less abuse potential than other substances in Schedules I and II of the Controlled Substances Act that the drug should be reclassified as Schedule III.

Proactive Investors • Aug 27, 2024

Cannabis stocks jump as Biden administration advances marijuana rescheduling proposal

US President Joe Biden confirmed on Thursday that the Justice Department is officially moving toward reclassifying cannabis as a lower-risk drug. The Justice Department's proposed rule will soon be posted which will be followed by a 60-day public comment period before the rule is potentially finalized, it was confirmed.

Proactive Investors • May 16, 2024